Bayer, Novartis clash with UK doctors over use of cheap eye drug

LONDON (Reuters) - Bayer is weighing legal action and Novartis has expressed concern at plans by doctors in the north of England to defy official guidance by using a cancer medicine as a cheap eye drug.

UK's NICE gives Roche drug green light for bladder cancer

LONDON (Reuters) - Britain's healthcare cost-effectiveness agency NICE, which decides if medicines should be used on the state health service, has decided Roche's immunotherapy drug Tecentriq is worth using to treat certain patients with bladder cancer.

U.S. experts set research agenda to meet 'Cancer Moonshot' goals

CHICAGO (Reuters) - It will take a major shift in the way cancer research is done in the United States to meet the ambitious goals set out by the U.S. Cancer Moonshot, researchers said on Tuesday.

Can spicy foods curb salt cravings or lower blood pressure?

(Reuters Health) - People who like spicy foods may eat less salt and have lower blood pressure, potentially reducing their risk of heart attacks and strokes, a study from China suggests.

FDA panel backs approval for Indivior opioid addiction drug

(Reuters) - Indivior Plc's experimental drug to treat opioid addiction is effective and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday.

Older patients having a heart attack often delay hospital trip

(Reuters Health) - A significant proportion of older people having heart attacks put off going to a hospital, a recent study found.

U.S. court bars Philips from selling some defibrillators

WASHINGTON (Reuters) - A federal court barred Philips North America LLC and two of its executives from distributing certain medical devices, including some of the company's external defibrillators, until the company takes remedial steps, the Department of Justice said on Tuesday.

Pesticide residue on fruits and veggies tied to infertility

(Reuters Health) - Women who eat more fruits and vegetables with high levels of pesticide residue may be less likely to get pregnant than women whose diets don’t include a lot of this type of produce, a U.S. study suggests.

U.S. FDA panel backs approval for Indivior opioid addiction drug

(Reuters) - Indivior Plc's experimental drug to treat opioid addiction should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday.

Neos Therapeutics to consider other offers after PDL snub: sources

(Reuters) - U.S. drugmaker Neos Therapeutics Inc, which this week rejected a fourth takeover offer by PDL Biopharma Inc, will consider offers from other potential buyers, according to people familiar with the matter.

Insys founder Kapoor steps down as Akorn chairman after arrest

NEW YORK (Reuters) - John Kapoor, the billionaire founder of opioid maker Insys Therapeutics Inc, has resigned as chairman of drugmaker Akorn Inc, just days after his arrest on charges he participated in a scheme to bribe doctors to prescribe a potent pain medication while he was at Insys.

U.S. states allege broad generic drug price-fixing collusion

WASHINGTON (Reuters) - A large group of U.S. states accused key players in the generic drug industry of a broad price-fixing conspiracy, moving on Tuesday to widen an earlier lawsuit to add many more drugmakers and medicines in an action that sent some company shares tumbling.

Work-family conflict helps explain gender gap in doctors’ depression

(Reuters Health) - Female doctors in training may be more likely to become depressed than their male counterparts at least in part because of difficulties balancing work with family life, a U.S. study suggests.